Setting new standards in information exchange for the pharmaceutical and biotech industry
Will Patients be Able to Pay to Get into a Clinical Trial?
December 17, 2014
Frustrated that a promising therapy for a rare cancer was sitting in a freezer due to the lack of a relatively modest amount of funding, author Alexander Masters helped lead a campaign to crowd-fund a clinical trial: the result, iCancer.org.uk. The money required was indeed raised – by one wealthy individual primarily, in return for being in the trial. Could this be a new paradigm to fund research gaps especially for rare diseases? What moral and ethical issues does this bring up?
We’re so pleased to announce that the scientist behind the virus, Professor Magnus Essand together with Alexander Masters will share their remarkable journey at the DPharm Europe event taking place in London on February 11th. For more information on the story see icancer.org.uk and
health/11189163/How-the- wealthy-paying-to-be-guinea- pigs-ini-clinical-trials- could-help-cure-us-all.html
For more information about Dpharm Europe, visit http://theconferenceforum.org/conferences/disruptive-innovations-europe/overview/